Cited by 34Acne and Rosacea Treatments and EffectsRetinoids in leukemia and cellular processesPsoriasis: Treatment and Pathogenesis

Retinoids: Fascinating Up‐and‐Coming Scenario

Sardana, Kabir, Sehgal, Virendra N.·2003·The Journal of Dermatology

Abstract

Retinoids have been in sharp focus ever since their introduction 30 years ago. They include any drug (s) that bind to retinoid receptors and elicit a biological response. Enormous information on the subject seems to embroil the recent literature. Practically it is impossible to clearly comprehend the undercurrents. The meticulously dispensing text envisages surmounting the perspective reader's predicaments. Accordingly, retinoids and their related facets namely retinoid receptors, classification, mode of action, and the pharmacological diversity have been precisely defined. Commonly used systemic retinoids too have been given a substantial fresh look along with their monitoring. Overall, adverse effects and relative and absolute contraindications have been scrupulously incorporated. Human immuno deficiency virus (HIV) and isoretinoid for acne, in particular, have been highlighted. Micronized isotretinoin formulations have also been taken care so also commonly used topical retinoids. Tretinoin and their newer formulation have also been accounted for along with tretinoin polymer cream. Adapalene, a new chemical entity possessing a unique physico‐chemical activity similar to that of tretinoin has also been dealt with. Newer retinoids are likely to be a subject of intrigue. A focus on future potentials of retinoids is its special ingredient. The inclusion of details of rexinoid the most recent introduction in their purview is likely to invoke interest to further consolidate its reckoning in future. All in all the text of the paper should provide an insight into the current rumbling around retinoids.

Integrity signals

Registry

Crossref · 10.1111/j.1346-8138.2003.tb00402.x

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sardana, K., & Sehgal, V. N.
Affiliations
  • Lady Hardinge Medical College (IN)
  • Dermato‐Venereology (Skin/VD) Centre Sehgal Nursing Home Panchwati, Azadpur, Delhi India
Corresponding author
Sehgal, Virendra N.
Venue
The Journal of Dermatology
Publisher
Wiley
Published
2003-05
Volume
30
Issue
5
Pages
355-380
ISSN
  • 0385-2407 (ISSN-L)
  • 1346-8138
OpenAlex
W1998903707
Cited by
34
References
85
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 1
FWCI
0.46
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
retinoids, retinoid receptors, mechanism of action, systemic retinoids, isotretinoin, all-trans retinoic acid, adapalene, HIV, adverse effects, contraindications, rexinoids, topical retinoids
MeSH terms
Adapalene, Acne Vulgaris, Administration, Cutaneous, Administration, Oral, Chemistry, Pharmaceutical, Humans, Naphthalenes, Psoriasis, Retinoids, Skin Diseases, Tretinoin, Isotretinoin, Receptors, Retinoic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review